Difference between revisions of "Team:Aix-Marseille/Collaborations"

(Proposition: Adding contention)
(Proposition: Adding contention)
Line 179: Line 179:
 
</ul>  
 
</ul>  
  
This model of toxin anti-toxin interaction takes into account the bacteriostatic nature of most such toxins,  
+
This model of toxin anti-toxin interaction takes into account the bacteriostatic nature of most such toxins,  
and the presence of measurable <div lang="latex">IC_{50}</div> values.
+
and the presence of measurable <div lang="latex">IC_{50}</div> values.
Clearly a more realsitic model would need to take into account cell volume, protein synthesis rates etc.
+
Clearly a more realsitic model would need to take into account cell volume, protein synthesis rates etc.
Nevertheless, this simple model gives:
+
Nevertheless, this simple model gives:
 +
 
 +
<div lang="latex">
 +
\mu &= \mu_{0} \times e^{-\frac{[Toxin]}{IC_{50}}} \\
 +
[Toxin] &= max(0,\frac{k_1z_1-k_2z_2}{k_3}) \\
 +
\mu &= \mu_{0} \times min(1.0,e^{-k_a(z_1-k_bz_2)}) \\
 +
k_a &= \frac{k_1}{k_3 \times IC_{50}} \\
 +
k_b &= \frac{k_2}{k_1}
 +
</div>
 +
 
 +
Incorporating 2 toxin anti toxin pairs,
 +
if we assume that the production rate ratio is the same for both, <div lang="latex">k_b</div>, is independant of the system we have:
 +
 
 +
<div lang="latex">\mu = \mu_{0} \times min(1,e^{-k_a(z_1-k_bz_2)})) \times min(1,e^{-k_a(z_2-k_bz_1)}))</div>
 +
 
 +
where $\mu_0$ is given by equation 3.
 +
For each toxin the efficiency parameter is a measure of ratio of toxin accumulation in cells with one gene copy and without anti-toxin to the <div lang="latex">IC_{50}</div>.
  
 
</html>
 
</html>

Revision as of 16:25, 17 October 2016